Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. The company has developed a therapeutic platform that targets validated and novel cancer antigens, focusing on improving antitumor efficacy through dual targeting of surface cancer molecules.